Literature DB >> 17065675

Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.

Jeffrey A Johnson1, Sheri L Pohar, Sumit R Majumdar.   

Abstract

OBJECTIVE: To analyze trends in health care costs in the decade after identification of diabetes, contrasting type 1 and 2 diabetes. RESEARCH DESIGN AND METHODS: The Canadian National Diabetes Surveillance System criteria were applied to administrative databases to identify incident diabetes cases in 1992. Cases were categorized as type 1 or type 2 diabetes based on patterns of drug use. Per capita health care costs (in 2001 Canadian dollars) for five resource categories were estimated according to the type of diabetes, for the year before identification (1991) and 10 years after (1992-2001) identification of the cases.
RESULTS: We identified 156 type 1 and 3,469 type 2 incident cases of diabetes, from a population base of approximately 950,000. The mean (+/-SD) age of case subjects at index was 61.2 +/- 16.7 years, and 54% of subjects were male. Overall annual per capita health expenditures rose considerably in the year after identification of diabetes but then stabilized at a lower level for the next 9 years, ranging from $3,800 to $4,400. From 1992 to 2001, diabetic individuals used $137.1 million in health care resources, most of which (96%) was attributable to type 2 diabetes. The average 10-year cost per individual with diabetes was $37,820 ($33,684 per type 1 and $38,006 per type 2 diabetes case; adjusted P = 0.45).
CONCLUSIONS: Total health expenditures for diabetes are driven by the much larger prevalence of type 2 compared with type 1 diabetes. Policymakers need to acknowledge and allocate resources for diabetes prevention and management accordingly.

Entities:  

Mesh:

Year:  2006        PMID: 17065675     DOI: 10.2337/dc06-0735

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.

Authors:  Heather J Galipeau; Nestor E Rulli; Jennifer Jury; Xianxi Huang; Romina Araya; Joseph A Murray; Chella S David; Fernando G Chirdo; Kathy D McCoy; Elena F Verdu
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

2.  Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland.

Authors:  R Lithovius; V Harjutsalo; C Forsblom; P H Groop
Journal:  Diabetologia       Date:  2010-12-07       Impact factor: 10.122

Review 3.  The role of the Human Metabolome Database in inborn errors of metabolism.

Authors:  Rupasri Mandal; Danuta Chamot; David S Wishart
Journal:  J Inherit Metab Dis       Date:  2018-04-16       Impact factor: 4.982

4.  Trajectory of Excess Medical Expenditures 10 Years Before and After Diabetes Diagnosis Among U.S. Adults Aged 25-64 Years, 2001-2013.

Authors:  Sundar S Shrestha; Ping Zhang; Israel A Hora; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

5.  Screening adults for pre-diabetes and diabetes may be cost-saving.

Authors:  Ranee Chatterjee; K M Venkat Narayan; Joseph Lipscomb; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

6.  Overview of the Canadian pediatric end-stage renal disease database.

Authors:  Susan M Samuel; Marcello A Tonelli; Bethany J Foster; Alberto Nettel-Aguirre; Yingbo Na; Robert Williams; Andrea Soo; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2010-08-26       Impact factor: 2.388

7.  Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

Authors:  Betty Tao; Massimo Pietropaolo; Mark Atkinson; Desmond Schatz; David Taylor
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

8.  Role of diabetes in the development of acute respiratory distress syndrome.

Authors:  Shun Yu; David C Christiani; B Taylor Thompson; Ednan K Bajwa; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

9.  Nationally representative medical costs of diabetes by time since diagnosis.

Authors:  Justin G Trogdon; Thomas Hylands
Journal:  Diabetes Care       Date:  2008-12       Impact factor: 19.112

Review 10.  Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.

Authors:  Nazia Raja-Khan; Sarah S Warehime; Robert A Gabbay
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.